08/06/2025
7:04 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2025
6:47 AM | Novavax (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/24/2025
5:37 PM | DOUGLAS RICHARD (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
5:39 PM | King Rachel K. (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
5:40 PM | MOTT DAVID M (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
5:40 PM | Novavax (Issuer)
Rodgers Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
5:35 PM | MCGLYNN MARGARET G (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
5:36 PM | Alton Gregg H (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
5:03 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2025
8:39 PM | MOTT DAVID M (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
8:40 PM | Novavax (Issuer)
Rodgers Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for NVAX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Novavax and its competitors with MarketBeat's FREE daily newsletter. |
06/13/2025
8:41 PM | King Rachel K. (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
8:36 PM | DOUGLAS RICHARD (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
6:01 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2025
6:34 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:26 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
6:59 AM | Novavax (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2025
8:25 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
5:01 AM | Novavax (Filer)
| Form DEFA14A | |
04/29/2025
7:51 AM | Novavax (Filer)
| Form DEF 14A | |
04/29/2025
7:54 AM | Novavax (Filer)
| Form ARS | |
04/29/2025
7:00 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2025
7:06 AM | Newton Charles W. (Reporting)
Novavax (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/29/2025
7:08 AM | Newton Charles W. (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2025
7:00 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2025
3:19 PM | Novavax (Subject)
YOUNG JAMES F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2025
1:52 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2025
7:03 PM | Novavax (Issuer)
Shiver John W. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/12/2025
7:04 PM | Novavax (Issuer)
Shiver John W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:33 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:34 PM | Novavax (Issuer)
Trizzino John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:30 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
4:03 PM | Jacobs John C (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
4:04 PM | Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
4:07 PM | Casey Mark J (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:39 PM | Novavax (Issuer)
O'Hara Elaine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:42 PM | Jacobs John C (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:43 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:46 PM | Casey Mark J (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:01 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
7:05 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
GENIUS Act: Cancel Your Money? (Ad) A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control.
Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live. Get the free info kit with 3 strategies to sidestep digital dollar control. |
02/27/2025
6:41 AM | Novavax (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/05/2025
6:04 PM | MCGLYNN MARGARET G (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
6:06 PM | Alton Gregg H (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Novavax (Subject)
| Form SCHEDULE 13G/A | |
01/27/2025
5:19 PM | Jacobs John C (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:50 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
4:41 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:52 PM | Novavax (Issuer)
Rodgers Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:44 PM | Novavax (Issuer)
YOUNG JAMES F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:47 PM | King Rachel K. (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:02 PM | Novavax (Subject)
YOUNG JAMES F (Reporting)
| Form 144/A | |
12/30/2024
4:27 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2024
9:31 AM | Novavax (Subject)
YOUNG JAMES F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024
4:24 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
4:24 PM | Casey Mark J (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
11:13 AM | King Rachel K. (Reporting)
Novavax (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2024
5:00 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
3:05 PM | Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2024
3:08 PM | Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
10:21 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
4:01 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
12:19 PM | Novavax (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/16/2024
7:00 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2024
3:08 PM | Dubovsky Filip (Reporting)
Novavax (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2024
3:47 PM | Novavax (Issuer)
Trizzino John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
4:06 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
7:04 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:37 AM | Novavax (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
